Skip to content

RealTime 09N77-095

by Abbott Molecular

RealTime 09N77-095 is a SARS-CoV-2 nucleic acid IVD (FDA product code QJR, Reagents, 2019-novel coronavirus nucleic acid) made by Abbott Molecular, listed in FDA GUDID since 27 Apr 2020 (UDI-DI 00884999049109), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00884999049109 UDI-DI Date27 Apr 2020ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Abbott RealTime SARS-CoV-2 Amplification Reagent Kit
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
RealTime
Generic name
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
09N77-095
Primary DI / UDI-DI
00884999049109
FDA product code
QJR
GMDN term
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
N
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT).

Other devices from Abbott Molecular

See all devices from Abbott Molecular →

Properties

  • Single use
  • Convenience kit
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)